SCHEMBL14656349

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL14670021	0.90	AR (0.52)	ARSLC22A12FNTAFNTBPGGT1B
	SCHEMBL14663667	0.89	AR (0.52)	ARSLC22A12FNTAFNTBPGGT1B
	SCHEMBL14656548	0.89	AR (0.52)	ARSLC22A12FNTAFNTBPGGT1B
	SCHEMBL14656359	0.87	AR (0.52)	ARSLC22A12FNTAFNTBPGGT1B
	SCHEMBL9889475	0.87	AR (0.52)	ARSLC22A12FNTAFNTBPGGT1B
	SCHEMBL875787	0.83	AR (0.67)	AR
	SCHEMBL29918437	0.83	AR (0.67)	AR
	SCHEMBL14656148	0.83	AR (0.56)	ARSLC22A12CYP2C8CYP2C9CYP2C19
	SCHEMBL14663528	0.82	AR (0.55)	ARSLC22A12
	SCHEMBL9900995	0.82	AR (0.55)	ARSLC22A12CYP2C8CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.